Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) Stock Price Today
Aura AI Summary
Key Stats
- $9.43BMarket Cap
- -Volume
- HealthSector
- $362.0852W High
- $241.7152W Low
- -Typical Hold Time
- $9.18BEnterprise Value
- -Div Yield
- -Trading Activity
Track Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Bio-Rad Laboratories, Inc. Class A Common Stock has traded between a low of $241.71 and a high of $362.08, highlighting its annual price range. Buy and sell Bio-Rad Laboratories, Inc. Class A Common Stock shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Most Recent News
Kyowa Kirin adopts AI platform Benchling to boost drug research efficiency in Japan.
Kyowa Kirin, a global specialty pharmaceutical company, is implementing the AI platform Benchling at its Tokyo and Fuji Research Parks to enhance research and development. Supported by Cognizant, Benchling will automate workflows, integrate data mana...
Capital One's Series I preferred shares stand out for dividends amid stable loan growth and strong credit health.
Capital One Financial offers five preferred share options, with Series I preferred shares favored for their higher dividend yield and lower sensitivity to interest rates. The bank's acquisition of Discover Financial has been smoothly integrated, supp...
Eaton Vance Tax-Managed Buy-Write Fund offers 8.19% yield with tech focus, trades at 7% discount amid cautious outlook.
The Eaton Vance Tax-Managed Buy-Write Opportunity Fund (ETV) provides investors with tech-heavy exposure and a monthly distribution yield of 8.19%. It currently trades at a 6.97% discount, which may attract income-focused investors. ETV employs an ag...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.